RETRACTION: Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC) (Retraction of Vol 2022, art no 1133332, 2022)

被引：0
|
作者：
Zhang, L.
机构：
来源：
BIOMED RESEARCH INTERNATIONAL | 2023年 / 2023卷
关键词：
D O I：
10.1155/2023/9864810
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] RETRACTION: Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma (Retraction of Vol 2021, art no 8893652, 2021)
    Sun, Q.
    Gong, X.
    Wu, J.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [42] RETRACTED: The lncRNA XIST promotes colorectal cancer cell growth through regulating the miR-497-5p/FOXK1 axis (Retracted Article)
    Wang, Nan
    He, Jia-Xing
    Jia, Guo-Zhan
    Wang, Ke
    Zhou, Shuai
    Wu, Tao
    He, Xian-Li
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [43] RETRACTION: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis (Retraction of Vol 19, art no 85, 2020)
    Liang, Yiran
    Song, Xiaojin
    Li, Yaming
    Chen, Bing
    Zhao, Wenjing
    Wang, Lijuan
    Zhang, Hanwen
    Liu, Ying
    Han, Dianwen
    Zhang, Ning
    Ma, Tingting
    Wang, Yajie
    Ye, Fangzhou
    Luo, Dan
    Li, Xiaoyan
    Yang, Qifeng
    MOLECULAR CANCER, 2022, 21 (01)
  • [44] RETRACTION: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis (Retraction of Vol 2022, art no 9500319, 2022)
    Guo, W. -W.
    Zhang, T. -W.
    Wang, B. -L.
    Mao, L. -Q.
    Li, X. -B.
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [45] Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis
    Gao, Su-Jie
    Ren, Sheng-Nan
    Liu, Yi-Ting
    Yan, Hong-Wei
    Chen, Xue-Bo
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 23 : 14 - 25
  • [46] RETRACTION: lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis (Retraction of Vol 13, Pg 4523, 2020)
    Wei, P.
    Yang, J.
    Zhang, D.
    Cui, M.
    Li, L.
    ONCOTARGETS AND THERAPY, 2022, 15 : 133 - 133
  • [47] RETRACTION: LncRNA SOX2-OTinhibitionprotects against myocardialischemia/reperfusion-inducedinjury via themicroRNA-186-5p (miR-186-5p)/Yin Yang 1 (YY1)pathway (vol 13, pg 280, 2022) (Retraction of Vol 13, Pg 280, 2022)
    Yang, Pengjie
    Liang, Kun
    Wang, Weisong
    Zhou, Dehua
    Chen, Yuan
    Jiang, Xueyan
    Fu, Rong
    Zhu, Benben
    Lin, Xuefeng
    BIOENGINEERED, 2024, 15 (01)
  • [48] RETRACTION: MCM3AP-AS1/miR-876-5p/WNT5A axis regulates the proliferation of prostate cancer cells (Retraction of Vol 20, art no 307, 2020)
    Wu, Jie
    Lv, Yalin
    Li, Yujun
    Jiang, Yanxia
    Wang, Lili
    Zhang, Xiangyan
    Sun, Mengqi
    Zou, Yuwei
    Xu, Jin
    Zhang, Li
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [49] RETRACTION: MiR-374b increases the CIK expression and mediates biological function changes in cervical cancer cells by targeting the PD-1/PD-L1 signaling pathway (Retraction of Vol 143, art no 103265, 2021)
    Wang Chunyan
    Kuang Lei
    Han Liwei
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 150
  • [50] RETRACTION: MiR-211-5p Inhibits the Biological Behaviors of Colorectal Cancer via SPARC-Related Growth Factor Pathways (Retraction of Vol 13, Pg 1895, 2022)
    Wu, X.
    JOURNAL OF CANCER, 2022, 13 (08): : 2418 - 2418
12345